NYSE:GLOBIT
Is Globant’s New AI Deals in Payments and Cancer Research Altering The Investment Case For Globant (GLOB)?
Earlier this week, Globant announced two major collaborations: becoming Adyen’s global lead integration partner for its payments platform and teaming with PharmaMar to deploy a multi‑agent AI system that sharply accelerates cancer drug discovery workflows.
Together, these agreements highlight how Globant is embedding its Enterprise AI and Financial Services AI Studio capabilities into mission‑critical payment and R&D infrastructures across industries.
Next, we’ll examine how Globant’s...